Amgen logo

Medical Science Liaison, Oncology - TX (Dallas), OK

Amgen
August 16, 2026
Remote friendly (Dallas, TX)
United States
Medical Affairs
Medical Science Liaison, Hematology Oncology - TX, OK
Territory: North Texas (Dallas), Oklahoma

What you will do
- Interact with Oncology healthcare decision makers to communicate and advance the scientific platform, particularly in prostate cancer.
- Communicate complex scientific information and research concepts to healthcare decision makers (including academic medical centers).
- Conduct clinical and pharmacoeconomic value discussions with payers and formulary decision makers.
- Identify and train members of Amgen’s speakers’ bureau and ensure they are updated on new data.
- Provide feedback based on field interactions and scientific support consistent with company goals.
- Provide clinical and economic value information to payers and formulary decision makers.
- Respond to investigator-sponsored research proposals.
- Support Amgen-sponsored research.
- Provide scientific support (per MSL compliance standards) for commercial/corporate accounts and matrix colleagues forwarding HCP inquiries.
- Foster scientific relationships with Fellows in training.
- Lead and/or participate on committees or project teams supporting MSL strategies/tactics.
- Mentor MSLs (as designated).

Basic Qualifications
- Doctorate degree
- Or Master’s degree + 3 years Medical Affairs experience
- Or Bachelor’s degree + 5 years Medical Affairs experience

Preferred Qualifications
- Pharm.D., Ph.D., M.D., or D.O. (other doctoral degrees considered)
- 3+ years medically related experience, including 1+ year focused on clinical practice, clinical research, or medical research (post-doctoral training may count)
- Current Scientific Affairs or Medical Affairs experience at a biotech/pharma company
- Oncology and/or Hematology therapeutic area expertise

Application instructions
- Apply via careers.amgen.com; Amgen accepts applications until a sufficient number is received or a candidate is selected.